TENOFOVIR ALAFENAMIDE (TAF) IN A SINGLE TABLET REGIMEN IN INITIAL HIV-1 THERAPY

被引：0

作者：

Pozniak, Anton ^{[1
]}

Wohl, David ^{[2
]}

Thompson, Melanie ^{[3
]}

DeJesus, Edwin ^{[4
]}

Podzamczer, Daniel

Molina, Jean Michel ^{[6
]}

Crofoot, Gordon ^{[7
]}

Callebaut, Christian ^{[5
]}

Martin, Hal ^{[5
]}

McCallister, Scott ^{[5
]}

机构：

[1] Chelsea & Westminster NHS Hosp, London, England

[2] North Carolina Dept Correct, North Carolina, Uganda

[3] AIDS Res Consortium Atlanta, Atlanta, GA USA

[4] Orlando Immunol Ctr, Orlando, FL USA

[5] Gilead Sci Inc, Foster City, CA 94404 USA

[6] Hop St Louis, Paris, Spain

[7] Premier Med Practice, Houston, France

来源：

SEXUALLY TRANSMITTED INFECTIONS | 2015年 / 91卷

关键词：

D O I：

10.1136/sextrans-2015-052126.143

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

P100

引用

页码：A49 / A49

页数：1

共 50 条

[1] Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study
Mills, Anthony
Crofoot, Gordon, Jr.
McDonald, Cheryl
Shalit, Peter
Flamm, Jason A.
Gathe, Joseph, Jr.
Scribner, Anita
Shamblaw, David
Saag, Michael
Cao, Huyen
Martin, Hal
Das, Moupali
Thomas, Anne
Liu, Hui C.
Yan, Mingjin
Callebaut, Christian
Custodio, Joseph
Cheng, Andrew
McCallister, Scott
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (04) : 439 - 445
[2] Tenofovir alafenamide (TAF) for treatment of HIV-1 in adults and adolescents: a provincial audit
Okonsukwa, J-M
Dhar, J.
Lenko, A.
[J]. HIV MEDICINE, 2019, 20 : 71 - 71
[3] Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1
Negredo, Eugenia
Clotet, Bonaventura
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (08) : 929 - 934
[4] The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIV
Stellbrink, H-J
Lazzarin, A.
Woolley, I
Llibre, J. M.
[J]. HIV MEDICINE, 2020, 21 : 3 - 16
[5] Switching to a single-tablet regimen bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) from dolutegravir (DTG) plus emtricitabine and either tenofovir alafenamide or tenofovir disoproxil fumarate (F/TAF or F/TDF)
Sax, P. E.
Rockstroh, J.
Luetkemeyer, A.
Yasdanpanah, Y.
Ward, D.
Trottier, B.
Rieger, A.
Liu, H.
Acosta, R.
Collins, S. E.
Brainard, D.
Martin, H.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 3 - 4
[6] Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected
Gallant, Joel
Brunetta, Jason
Crofoot, Gordon
Benson, Paul
Mills, Anthony
Brinson, Cynthia
Oka, Shinichi
Cheng, Andrew
Garner, Will
Fordyce, Marshall
Das, Moupali
McCallister, Scott
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (03) : 294 - 298
[7] TENOFOVIR (TFV) ALAFENAMIDE (TAF) DOSE IN THE FIRST PIBASED SINGLE TABLET REGIMEN (STR) DARUNAVIR/COBICISTAT/EMTRICITABINE/TAF (DRV/COBI/FTC/TAF; D/C/F/TAF).
Custodio, J. M.
Wei, X.
Wang, H.
Hepner, M.
Zack, J. Z.
Callebaut, C.
McCallister, S.
Miller, M.
Kearney, B. P.
Ramanathan, S.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S36 - S36
[8] Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients
Ogbuagu, Onyema
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (12) : 1113 - 1126
[9] FDA approves a single tablet regimen for HIV-1
不详
[J]. NURSE PRACTITIONER, 2016, 41 (06): : 64 - 64
[10] Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies)
Oliver Ackaert
David McDougall
Carlos Pérez-Ruixo
Juan Jose Pérez-Ruixo
John Jezorwski
Herta M. Crauwels
[J]. The AAPS Journal, 23

← 1 2 3 4 5 →